EMOttawa Blog
  • Ottawa Handbook of Emergency Medicine
  • EMOttawa Podcast
  • Point-of-Care Echo
  • Grand Round Summaries
  • Journal Club
  • Commentary
  • Ultrasound
  • Infographics
  • Canadian TIA Score
  • EDI
  • Prehospital and Transport Medicine
  • Ottawa Acute Care Resources
  • About Us
Select Page
Prevalence of Pulmonary Embolism Among Patients With COPD Hospitalized With Acutely Worsening Respiratory Symptoms

Prevalence of Pulmonary Embolism Among Patients With COPD Hospitalized With Acutely Worsening Respiratory Symptoms

by Hans Rosenberg | May 31, 2021 | Journal Club, Respirology, Thrombosis

Methodology: 3/5 Usefulness: 3/5 Couturaud F, et al. JAMA. 2021 Jan 5;325(1):59-68.  Question and Methods: This study used a multicenter, cross-sectional methodology with prospective follow up to determine the rates of PE in 740 COPD patients using the rGeneva score....
Thrombolytic Therapy: A Stroke of Luck? Part 2

Thrombolytic Therapy: A Stroke of Luck? Part 2

by Doran Drew, Josee Malette | May 27, 2021 | Featured, Grand Round Summaries, Neurology, Thrombosis

Addressing the Controversies Around Thrombolytic Therapy (tPA) In our previous blog post, we reviewed the formative literature supporting the currently used tPA time window. The figure below highlights a summary of the time windows investigated within each study and...
Thrombolytic Therapy: A Stroke of Luck? Part 1

Thrombolytic Therapy: A Stroke of Luck? Part 1

by Doran Drew, Josee Malette, Kate O'Connell | May 20, 2021 | Featured, Grand Round Summaries, Neurology, Thrombosis

Review of the formative literature of our current tPA time window in Acute Ischemic Stroke  After numerous case series and smaller prospective studies suggesting benefit for thrombolytic therapy (tPA), the early 90s ushered in the era of thrombolytic RCTs for acute...
The Use of Tranexamic Acid to Reduce the Need for Nasal Packing in Epistaxis (NoPAC): Randomized Controlled Trial

The Use of Tranexamic Acid to Reduce the Need for Nasal Packing in Epistaxis (NoPAC): Randomized Controlled Trial

by Hans Rosenberg | May 10, 2021 | ENT, Featured, Journal Club, Thrombosis

Methodology: 3/5 Usefulness: 3/5 Reuben A, et al. Ann Emerg Med. 2021 Feb 18:S0196-0644(20)31461-X. Question and Methods: This was a double-blind, randomized controlled trial comparing topical tranexamic acid to placebo in patients presenting to the ED with epistaxis...
The D-Dimer Dilemma: It’s Use In Low-Risk PE

The D-Dimer Dilemma: It’s Use In Low-Risk PE

by Jim Yang, Kaitlin Endres, Josee Malette | Nov 19, 2020 | Critical Care, Featured, Grand Round Summaries, Medical Education, Thrombosis

Pulmonary embolism is often a nebulous diagnosis with various nuances. COMMON: They affect 25-100 people per 100,000, or approximately 30,000 Canadians every year Potentially FATAL: 3rd most deadly cardiovascular disease, after Heart Attack and Stroke Associated with...
Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial

Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial

by Hans Rosenberg | Nov 16, 2020 | Critical Care, Journal Club, Resuscitation, Thrombosis, Trauma

Methodology: 4/5 Usefulness: 3.5/5 Baksaas-Aasen K, et al. Intensive Care Med. 2020 Oct 13. doi: 10.1007/s00134-020-06266-1.  Question and Methods: Pragmatic, European, multi-center RCT comparing outcomes in trauma patients who received empiric massive transfusion...
Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes

Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes

by Hans Rosenberg | Mar 23, 2020 | Cardiology, Featured, Journal Club, Thrombosis

Methodology Score: 4/5 Usefulness Score: 4/5 Schüpke S, et al N Engl J Med. 2019 Oct 17;381(16):1524-1534. Editorial: Ticagrelor or Prasugrel in Acute Coronary Syndromes – The Winner Takes It All? Question and Methods: This open-label multicenter trial was the...
Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability

Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability

by Hans Rosenberg | Feb 10, 2020 | Journal Club, landmark, Thrombosis

Methodology Score: 4/5 Usefulness Score: 4.5/5 Kearon C, et al. N Engl J Med. 2019 Nov 28;381(22):2125-2134 Question and Methods: the authors sought to demonstrate safety using a d-dimer cut-off of 1000ng/mL for low pre-test probability patients & a cut-off of...
Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism

Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism

by Hans Rosenberg | Aug 19, 2019 | Journal Club, OBGYN, Thrombosis

Journal Club Summary Methodology Score: 4.5/5 Usefulness Score: 4.5 /5 van der Pol LM, et al. N Engl J Med. 2019 Mar 21;380(12):1139-1149 Question and Methods: Using a prospective cohort study of 510 pregnant women, the authors were trying to see whether an algorithm...
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors

Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors

by Hans Rosenberg | May 13, 2019 | Journal Club, Thrombosis

Journal Club Summary Methodology: 2.5/5 Usefulness: 2/5 Connolly SJ, et al. N Engl J Med. 2019 Feb 7. Question and Methods: This was the first trial looking at clinical outcomes for reversal of factor Xa inhibitor anticoagulation in major bleeding episodes using the...
« Older Entries
Next Entries »
  • Facebook
  • Twitter
  • Instagram
  • YouTube

Mission Statement

World-Class Emergency Medicine: To provide outstanding compassionate emergency care through practice-changing research and innovative medical education. For more about our department, visit us at EMOttawa.

Categories

Mission Statement

World-Class Emergency Medicine: To provide outstanding compassionate emergency care through practice-changing research and innovative medical education. For more about our department, visit us at EMOttawa.

Categories

Archives

Free Open Access Medical Education content by EMOttawa is under a Creative Commons Attribution-NonCommercial ShareAlike 4.0 International License.